BamSEC and AlphaSense Join Forces
Learn More

Immunic Inc. – Underwriting Agreements

NASDAQ: IMUX    
Share price (8/21/26): $16.50    
Market cap (8/21/26): $225 million

Underwriting Agreements Filter

EX-1
from SCHEDULE 13G/A 1 page Joint Filing Agreement
12/34/56
EX-1
from SCHEDULE 13G 1 page Joint Filing Agreement
12/34/56
EX-1
from SCHEDULE 13G ~1 page Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 47 pages Immunic, Inc. (A Delaware Corporation) Pre-Funded Warrants to Purchase 86,666,667 Shares of Common Stock Series a Warrants to Purchase 86,666,667 Shares of Common Stock Series B Warrants to Purchase 86,666,667 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 48 pages 4,500,000 Shares Immunic, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13G/A ~1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1.1
from 8-K 42 pages 5,000,000 Shares Immunic, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13G 2 pages Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 32 pages 8,750,000 Shares
12/34/56
EX-1.1
from 8-K 36 pages 5,454,546 Shares Vital Therapies, Inc. Common Stock Underwriting Agreement October 22, 2015
12/34/56
EX-1.2
from S-3 46 pages Vital Therapies, Inc. Up to $75,000,000 of Shares of Common Stock (Par Value $0.0001 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-1.1
from S-1/A 38 pages [—] Shares Vital Therapies, Inc. Common Stock Underwriting Agreement [—], 2014
12/34/56
EX-1.1
from S-1/A 42 pages [—] Shares Vital Therapies, Inc. Common Stock Underwriting Agreement [—], 2014
12/34/56
EX-1.1
from S-1/A 36 pages [—] Shares Vital Therapies, Inc. Common Stock Underwriting Agreement [—], 2013
12/34/56